Trial NCT03067571

View at ClinicalTrials.gov 
Org. Study IDs: 2016-0889
Secondary IDs: 2016-0889 NCI-2018-01222

Last trial update was posted on 2023-09-21

MeSH Interventions

Daratumumab

MeSH Conditions

Leukemia Leukemia, Myeloid Leukemia, Myeloid, Acute Myelodysplastic Syndromes Preleukemia Syndrome

Other Conditions

High Risk Myelodysplastic Syndrome Recurrent Acute Myeloid Leukemia Refractory Acute Myeloid Leukemia

Stopping Reasons

Study terminated early because of lack of efficacy

Limitations And Caveats

N/A

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID